glp-1 obesity drug news today oct 2025 Compound versions of drugs for weight loss halted by FDA glp-1 news oct 16 2025

Key Takeaways The data surrounding islet cell therapies is very exciting, but we have more work to do until manufactured products are accessible to everyone with T1D who may want them

Heart rate should be monitored at regular intervals consistent with usual clinical practice in patients taking semaglutide and patients should inform health care providers of palpitations or feelings of a racing heartbeat while at rest during semaglutide treatment

It binds with toxins to form a water-soluble complex that can be excreted through the liver

A 2006 review of the field by an active research group described DSIP as a still unresolved riddle a description that, twenty years later, the published literature has not displaced (Kovalzon & Strekalova, 2006)

Early pregnancy losses and increased incidences of minor visceral (kidney, liver) and skeletal (sternebra) fetal abnormalities were observed at 0.0025 mg/kg/day, at clinically relevant exposures